Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Yanguas Casás, Natalia ^a   Barreda Manso, M A ^a,b   Nieto Sampedro, Manuel ^a,b   Romero Ramírez, Lorenzo ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

Author keywords

Astrocytes; Bile salts; Inducible nitric oxide synthase; Lipopolysaccharide; Microglia; Migration; Monocyte chemotactic protein 1; NF B; Protein kinase RNA activated; Vascular cell adhesion molecule 1

Indexed keywords

GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE PROTEIN; NITRITE; PROTEIN IBA 1; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; CHOLAGOGUE; LIPOPOLYSACCHARIDE; TAUROCHENODEOXYCHOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; ENCEPHALITIS; ENZYME INHIBITION; GLIA CELL; HIPPOCAMPUS; IMMUNOREACTIVITY; IN VITRO STUDY; MICROGLIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GLIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; NEWBORN; PATHOLOGY; TOXICITY; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHOLAGOGUES AND CHOLERETICS; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; NEUROGLIA; NITRITES; RATS, WISTAR; TAUROCHENODEOXYCHOLIC ACID; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84897935360     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-50     Document Type: Article

References (32)

1. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001, 36:180-190. 10.1002/glia.1107, 11596126.
2. Aloisi F. Immune function of microglia. Glia 2001, 36:165-179. 10.1002/glia.1106, 11596125.
3. Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 2003, 358:1669-1677. 10.1098/rstb.2003.1358, 1693261, 14561325.
4. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006, 147(Suppl 1):S232-S240. 1760754, 16402109.
5. Aloisi F, Ambrosini E, Columba-Cabezas S, Magliozzi R, Serafini B. Intracerebral regulation of immune responses. Ann Med 2001, 33:510-515. 10.3109/07853890108995960, 11730157.
6. Hausmann ON. Post-traumatic inflammation following spinal cord injury. Spinal Cord 2003, 41:369-378. 10.1038/sj.sc.3101483, 12815368.
7. Popovich PG, Guan Z, McGaughy V, Fisher L, Hickey WF, Basso DM. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol 2002, 61:623-633.
8. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995, 21:195-218. 10.1016/0165-0173(95)00011-9, 8866675.
9. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease - a double-edged sword. Neuron 2002, 35:419-432. 10.1016/S0896-6273(02)00794-8, 12165466.
10. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397. 10.1016/S0166-2236(99)01401-0, 10441299.
11. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 2002, 8:101-105. 10.1097/00075198-200204000-00002, 12386508.
12. Bauer J, Rauschka H, Lassmann H. Inflammation in the nervous system: the human perspective. Glia 2001, 36:235-243. 10.1002/glia.1112, 11596131.
13. Schroeter M, Jander S. T-cell cytokines in injury-induced neural damage and repair. Neuromolecular Med 2005, 7:183-195. 10.1385/NMM:7:3:183, 16247179.
14. Gaspar JM, Martins A, Cruz R, Rodrigues CM, Ambrosio AF, Santiago AR. Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose. Neuroscience 2013, 253:380-388.
15. Rodrigues CM, Spellman SR, Sola S, Grande AW, Linehan-Stieers C, Low WC, Steer CJ. Neuroprotection by a bile acid in an acute stroke model in the rat. J Cereb Blood Flow Metab 2002, 22:463-471.
16. Colak A, Kelten B, Sagmanligil A, Akdemir O, Karaoglan A, Sahan E, Celik O, Barut S. Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats. J Clin Neurosci 2008, 15:665-671. 10.1016/j.jocn.2007.06.002, 18343118.
17. Keene CD, Rodrigues CM, Eich T, Chhabra MS, Steer CJ, Low WC. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A 2002, 99:10671-10676. 10.1073/pnas.162362299, 125009, 12149470.
18. Rodrigues CM, Sola S, Nan Z, Castro RE, Ribeiro PS, Low WC, Steer CJ. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci U S A 2003, 100:6087-6092. 10.1073/pnas.1031632100, 156330, 12721362.
19. Joo SS, Won TJ, Lee DI. Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch Pharm Res 2004, 27:954-960. 10.1007/BF02975850, 15473667.
20. Poupon RE, Poupon R, Balkau B, The UDCA-PBC Study Group Ursodiol for the long-term treatment of primary biliary cirrhosis. N Eng J Med 1994, 330:1342-1347. The UDCA-PBC Study Group.
21. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates 1997, San Diego: Academic.
22. Mecha M, Mestre L, Hernangómez M, Borrell J, Guaza C. An easy and fast way to obtain a high number of glial cells from rat cerebral tissue: a beginners approach. Protocol Exchange 2011, 218. doi:10.1038/protex.2011.218.
23. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980, 85:890-902. 10.1083/jcb.85.3.890, 2111442, 6248568.
24. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids. Anal Biochem 1982, 126:131-138. 10.1016/0003-2697(82)90118-X, 7181105.
25. Saura M, Zaragoza C, Diaz-Cazorla M, Hernandez-Perera O, Eng E, Lowenstein CJ, Perez-Sala D, Lamas S. Involvement of transcriptional mechanisms in the inhibition of NOS2 expression by dexamethasone in rat mesangial cells. Kidney Int 1998, 53:38-49. 10.1046/j.1523-1755.1998.00725.x, 9452998.
26. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999, 274:10689-10692. 10.1074/jbc.274.16.10689, 10196138.
27. Yin JX, Tu JL, Lin HJ, Shi FD, Liu RL, Zhao CB, Coons SW, Kuniyoshi S, Shi J. Centrally administered pertussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse model. PLoS One 2010, 5:e12400. 10.1371/journal.pone.0012400, 2928301, 20811645.
28. Carrigan SO, Pink DB, Stadnyk AW. Neutrophil transepithelial migration in response to the chemoattractant fMLP but not C5a is phospholipase D-dependent and related to the use of CD11b/CD18. J Leukoc Biol 2007, 82:1575-1584. 10.1189/jlb.0806528, 17724165.
29. Cabanski M, Steinmuller M, Marsh LM, Surdziel E, Seeger W, Lohmeyer J. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. Am J Respir Cell Mol Biol 2008, 38:26-31. 10.1165/rcmb.2007-0010OC, 17690330.
30. Bonnet MC, Weil R, Dam E, Hovanessian AG, Meurs EF. PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol Cell Biol 2000, 20:4532-4542. 10.1128/MCB.20.13.4532-4542.2000, 85837, 10848580.
31. Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, Sonenberg N, Harding HP, Ron D. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol 2004, 24:10161-10168. 10.1128/MCB.24.23.10161-10168.2004, 529034, 15542827.
32. Weiss N, Miller F, Cazaubon S, Couraud PO. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 2009, 1788:842-857. 10.1016/j.bbamem.2008.10.022, 19061857.